• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用紫杉醇洗脱支架成功治疗覆膜支架移植物的支架内再狭窄。

Successful treatment of in-stent restenosis of a covered stent graft with a paclitaxel-eluting stent.

作者信息

Thani Khalid Bin, Bennett William E, Ravandi Amir, Tsimikas Sotirios

机构信息

Interventional Cardiology and Cardiovascular Catheterization Lab, UCSD Medical Center, 200 West Arbor Drive, San Diego, CA, USA.

出版信息

J Cardiol Cases. 2011 May 4;4(1):e13-e15. doi: 10.1016/j.jccase.2011.03.008. eCollection 2011 Aug.

DOI:10.1016/j.jccase.2011.03.008
PMID:30532863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6265220/
Abstract

We present the case of a 58-year-old male with coronary artery disease and a significant stenosis of the left circumflex artery that was preceded by a coronary aneurysm. The stenosis and aneurysm were treated successfully with a coronary stent graft. The patient subsequently developed in-stent restenosis (ISR). The ISR was then successfully treated with a paclitaxel-eluting stent (PES). The patient has been followed clinically for 4-6 years without recurrence of his anginal symptoms. This is the first description in the literature of which we are aware of the successful treatment of an ISR of a coronary stent graft with a PES with persistent long-term clinical effectiveness.

摘要

我们报告了一例58岁男性患者,患有冠状动脉疾病,左旋支动脉存在严重狭窄,且之前有冠状动脉瘤。该狭窄和动脉瘤通过冠状动脉支架移植物成功治疗。患者随后发生了支架内再狭窄(ISR)。然后用紫杉醇洗脱支架(PES)成功治疗了ISR。该患者已接受临床随访4至6年,心绞痛症状未复发。据我们所知,这是文献中首次描述用PES成功治疗冠状动脉支架移植物的ISR并具有持续长期临床疗效。

相似文献

1
Successful treatment of in-stent restenosis of a covered stent graft with a paclitaxel-eluting stent.使用紫杉醇洗脱支架成功治疗覆膜支架移植物的支架内再狭窄。
J Cardiol Cases. 2011 May 4;4(1):e13-e15. doi: 10.1016/j.jccase.2011.03.008. eCollection 2011 Aug.
2
Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.使用紫杉醇涂层球囊血管成形术治疗药物洗脱支架内再狭窄:来自法国“真实世界”前瞻性GARO注册研究的见解。
Int J Cardiol. 2016 Jan 15;203:690-6. doi: 10.1016/j.ijcard.2015.11.031. Epub 2015 Nov 6.
3
Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis.依维莫司洗脱支架与紫杉醇洗脱支架治疗金属裸支架再狭窄。
Am J Cardiol. 2011 Aug 15;108(4):518-22. doi: 10.1016/j.amjcard.2011.03.080. Epub 2011 May 31.
4
One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.CRISTAL 试验的一年结果,对药物洗脱支架再狭窄的西罗莫司洗脱冠状动脉雷帕霉素洗脱支架与球囊血管成形术的随机比较。
J Interv Cardiol. 2012 Dec;25(6):586-95. doi: 10.1111/j.1540-8183.2012.00769.x. Epub 2012 Sep 20.
5
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.紫杉醇洗脱支架置入术后最小支架面积对 9 个月随访通畅率的影响:来自 TAXUS IV、V、VI 及 TAXUS ATLAS Workhorse、长病变、直接支架试验的血管内超声综合分析。
JACC Cardiovasc Interv. 2009 Dec;2(12):1269-75. doi: 10.1016/j.jcin.2009.10.005.
6
Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.PEPCAD中国药物洗脱支架内再狭窄试验的两年结果及亚组分析:一项治疗药物洗脱支架内再狭窄的前瞻性、多中心、随机试验。
Catheter Cardiovasc Interv. 2016 Mar;87 Suppl 1:624-9. doi: 10.1002/ccd.26401. Epub 2016 Jan 17.
7
Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy.使用紫杉醇洗脱支架治疗支架内再狭窄:与冠状动脉内β射线放疗配对比较的急性结果和长期随访
Eur Heart J. 2004 Jun;25(11):920-5. doi: 10.1016/j.ehj.2004.02.014.
8
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.药物洗脱支架置入治疗无保护左主干冠状动脉疾病后,冠状动脉解剖结构和支架技术对长期预后的影响。
JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.
9
A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial.紫杉醇涂层球囊与紫杉醇洗脱支架治疗药物洗脱支架内再狭窄的前瞻性、多中心、随机试验:来自 PEPCAD China ISR 试验的结果。
JACC Cardiovasc Interv. 2014 Feb;7(2):204-211. doi: 10.1016/j.jcin.2013.08.011.
10
Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.紫杉醇洗脱支架与西罗莫司洗脱支架相比,支架断裂相关再狭窄风险降低:长期随访结果。
Catheter Cardiovasc Interv. 2012 Mar 1;79(4):559-65. doi: 10.1002/ccd.23031. Epub 2011 May 12.

本文引用的文献

1
SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.SPIRIT IV试验设计:依维莫司洗脱支架与紫杉醇洗脱支架用于冠心病患者的大规模随机对照比较
Am Heart J. 2009 Oct;158(4):520-526.e2. doi: 10.1016/j.ahj.2009.07.025. Epub 2009 Aug 26.
2
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.依维莫司洗脱支架与紫杉醇洗脱支架的随机对照比较:来自Xience V依维莫司洗脱冠状动脉支架系统治疗初发原发性冠状动脉病变患者的临床评估(SPIRIT)III试验的两年临床随访
Circulation. 2009 Feb 10;119(5):680-6. doi: 10.1161/CIRCULATIONAHA.108.803528. Epub 2009 Jan 26.
3
Delayed endothelialization after polytetrafluoroethylene-covered stent implantation for coronary aneurysm.聚四氟乙烯覆膜支架植入治疗冠状动脉瘤后内皮化延迟
Circ J. 2009 Jan;73(1):190-3. doi: 10.1253/circj.cj-07-0924. Epub 2008 Nov 11.
4
Covered stents: a review.覆膜支架:综述
Int J Cardiol. 2008 Nov 28;130(3):310-8. doi: 10.1016/j.ijcard.2008.04.083. Epub 2008 Jul 30.
5
Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.紫杉醇洗脱支架或近距离放射治疗裸金属支架再狭窄后的两年临床结局:TAXUS V ISR试验
Eur Heart J. 2008 Jul;29(13):1625-34. doi: 10.1093/eurheartj/ehn231. Epub 2008 Jun 13.
6
Percutaneous treatment of a large coronary aneurysm using the self-expandable Symbiot PTFE-covered stent.使用自膨胀式Symbiot聚四氟乙烯覆膜支架经皮治疗大型冠状动脉瘤。
Chest. 2004 Aug;126(2):644-5. doi: 10.1378/chest.126.2.644.
7
Successful exclusion of a left main coronary artery aneurysm with a PTFE-covered coronary stent.使用聚四氟乙烯涂层冠状动脉支架成功排除左主干冠状动脉瘤。
J Invasive Cardiol. 2004 Aug;16(8):433-4.
8
Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial.聚四氟乙烯覆膜支架在大隐静脉移植血管中的随机评估:聚四氟乙烯覆膜支架在大隐静脉移植血管中的随机评估(RECOVERS)试验
Circulation. 2003 Jul 8;108(1):37-42. doi: 10.1161/01.CIR.0000079106.71097.1C. Epub 2003 Jun 23.
9
Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results.Jostent冠状动脉支架移植物在各种临床情况下的植入结果:手术及随访结果。
Catheter Cardiovasc Interv. 2002 Jul;56(3):353-60. doi: 10.1002/ccd.10223.
10
Polytetrafluoroethylene-covered stent and coronary artery aneurysms.聚四氟乙烯覆膜支架与冠状动脉瘤
Catheter Cardiovasc Interv. 2002 Mar;55(3):326-30. doi: 10.1002/ccd.10063.